You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 2, February 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  COMMENTS AND OPINIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Zinc and Essential Fatty Acid Therapy for Necrolytic Migratory Erythema

J. L. Burton, MD
Department of Dermatology Bristol Royal Infirmary Bristol, England BS2 8HW

Arch Dermatol. 1993;129(2):246.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Hanson,1 in his interesting review of dermatitis related to nutritional deficiency that appeared in the October 1992 issue of the ARCHIVES, points out that signs of zinc deficiency can be largely reversed by giving essential fatty acids, and he mentions the clinical similarity between the rashes of glucagonoma syndrome, acrodermatitis enteropathica, and the newly recognized dermatitis associated with cystic fibrosis.

The suggestion that these eruptions may be related to zinc, protein, and essential fatty acid deficiency is supported by two recent British case reports.2,3 In the first case report, a 46-year-old woman with malignant glucagonoma developed necrolytic migratory erythema, which rapidly cleared with omega-3 essential fatty acids (Maxepa, 10 capsules daily) There was a concomitant improvement in her general well being. The skin remained clear until the omega-3 fatty acids were no longer administered, when the rash recurred. The rash cleared again when the omega-3 . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.